Faecal calprotectin (FC) in secondary care: unnecessarily complex or definitely helpful?: Table 1

  • Srinivas M
  • Eyre R
  • Walsh M
  • et al.
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Introduction Faecal calprotectin (FC) is a protein complex released from degraded neutrophils exuded through the gut wall into the lumen. Its levels are therefore likely to better refl ect the presence and intensity of gut infl ammation than our conventional infl ammatory markers: C reactive protein (most commonly used by us), platelets, albumin, endoscopy, histopathology and imaging. FC values (mg/kg) suggest infl ammatory status as <50:Nil; 50-100: possible; >100: likely; >1000: definite. The factors limiting its routine use include need for spot stool collection, which many patients dislike and the time involved for manual assay, hence higher cost. Is the 'help' in decision making worth the effort and cost? Aim To test the utility of FC in the routine clinical setting of a gastroenterology unit in a UK DGH. Methods Retrospective study of consecutive new and follow up patients who had FC (PhiCal ELISA test) done in our clinics between 10/2007 and 2/2009 (n = 200). Patients were categorised into IBD-fl are (relapse), IBD-active (persistent activity), IBD-remission and non-IBD (eg, IBS, abdominal pain, weight loss). The spot FC values are tabulated as median and range according to presence or absence of infl ammation by conventional markers as above (≥ 1 test done within 2 weeks in majority). Results See table 1. Conclusion FC levels > 500 correlate well with fl are and active IBD. Very low levels (< 7.8) reliably indicate lack of significant GI infl ammation. Levels > 7.8 in non-IBD patients (majority of new referrals) may indicate ongoing GI infl ammation in a few and hence the need to investigate fully rather than assume functional GI disease as the FC levels are within the published “normal” range. Raised FC in IBD-remission may signify ongoing silent infl ammation with potentially significant infl uence on long-term prognosis (an area to be explored). Discussion This retrospective pilot study in our unit suggests that the effort and cost of FC is exceeded by the help it offers. It is of definite help when levels are very high or very low. We need to assess systematically the disease correlation with moderate FC elevation to develop local normal values. (Table presented).

Cite

CITATION STYLE

APA

Srinivas, M., Eyre, R., Walsh, M., Basumani, P., Hoeroldt, B., Willemse, P., & Bardhan, K. (2011). Faecal calprotectin (FC) in secondary care: unnecessarily complex or definitely helpful?: Table 1. Gut, 60(Suppl 1), A50.1-A50. https://doi.org/10.1136/gut.2011.239301.98

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free